Table 3 Pathway analysis for AVMs’ differential expressed genes
From: Human brain arteriovenous malformation: an analysis of differential expressed genes
Pathway | P-value (%) | Q-value (%) | Gene | FC |
|---|---|---|---|---|
MAPK signaling pathway | 0.219 | 0.0 | DUSP2 | 0.36 |
Cell adhesion molecules | 0.113 | 0.0 | VCAN | 2.60 |
Tight junction | 0.114 | 0.0 | HCLS1 | 2.53 |
Galactose metabolism | 0.023 | 0.0 | GANC | 3.36 |
Primary immunodeficiency | 0.031 | 0.0 | CD3D | 2.57 |
Starch and sucrose metabolism | 0.046 | 0.0 | GANC | 3.36 |
Pathogenic Escherichia coli infection | 0.048 | 0.0 | HCLS1 | 2.53 |
Natural killer cell mediated cytotoxicity | 0.116 | 0.0 | KLRK1 | 0.39 |
Regulation of actin cytoskeleton | 0.178 | 0.0 | TMSB4Y | 1.51 |